Anti-alpha1,3-galactose-mediated hyperacute rejection of vascularized transplants in a small animal model.
Gock
H
H
Immunology Research Centre, St Vincent's Hospital, Melbourne, Australia.
Salvaris
E
E
Han
W
W
Murray-Segal
L
L
Mottram
P
P
Cowan
P
P
Goodman
D J
DJ
d'Apice
A J
AJ
D000208:Acute Disease; D000818:Animals; D000910:Antibodies, Heterophile / Q000032:analysis*; D004187:Disaccharides / Q000276:immunology*; D000939:Epitopes / Q000276:immunology; D004910:Erythrocyte Membrane / Q000276:immunology; D005700:Galactosyltransferases / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D006084:Graft Rejection / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D051379:Mice; D018345:Mice, Knockout; D023421:Models, Animal; D011817:Rabbits; D014183:Transplantation, Heterologous / Q000276:immunology*
D000910:Antibodies, Heterophile; D004187:Disaccharides; D000939:Epitopes; C055075:galactosyl-(1-3)galactose; D005700:Galactosyltransferases; C047006:N-acetyllactosaminide alpha-1,3-galactosyltransferase